Patent details

EP2869843 Title: COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

Basic Information

Publication number:
EP2869843
PCT Application Number:
EP2013063750
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137365185
PCT Publication Number:
WO2014005959
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPLEXES OF CYTOMEGALOVIRUS PROTEINS
French Title of Invention:
COMPLEXES DE PROTÉINES DE CYTOMÉGALOVIRUS
German Title of Invention:
KOMPLEXE VON CYTOMEGALOVIRUSPROTEINEN
SPC Number:

Dates

Filing date:
29/06/2013
Grant date:
07/08/2019
EP Publication Date:
13/05/2015
PCT Publication Date:
09/01/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/06/2020
Expiration date:
29/06/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:
CARFI, Andrea
Address:
United States (US)

2

Name:
WEN, Yingxia
Address:
United States (US)

Priority

1

Priority Number:
201261668975 P
Priority Date:
06/07/2012
Priority Country:
United States (US)

2

Priority Number:
201361770257 P
Priority Date:
27/02/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/245; C07K 14/045; C12N 7/02;

Publication

European Patent Bulletin

1

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

2

Issue number:
202025
Publication date:
17/06/2020
Description:
Opposition procedure started

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages